OVARIAN HIGH-GRADE SEROUS CARCINOMA WITH NEUROENDOCRINE COMPONENT, A RARE AND AGGRESSIVE TUMOR

被引:0
|
作者
Kumar, V. [1 ]
Shalaby, A. [1 ]
Manucha, V. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
关键词
D O I
10.1136/jim-2020-SRM.197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
197
引用
收藏
页码:513 / 514
页数:2
相关论文
共 50 条
  • [31] Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma
    Matsumoto, Toshihide
    Oda, Yusuke
    Hasegawa, Yoshinori
    Hashimura, Miki
    Oguri, Yasuko
    Inoue, Hisako
    Yokoi, Ako
    Tochimoto, Masataka
    Nakagawa, Mayu
    Jiang, Zesong
    Saegusa, Makoto
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (10): : 1837 - 1850
  • [32] Undiagnosed tubal high-grade serous carcinoma metastatic to synchronous benign ovarian Brenner tumor
    Chougule, Abhijit
    Garg, Rashi
    Dey, Pranab
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 162 - +
  • [33] Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma
    Peres, Lauren C.
    Colin-Leitzinger, Christelle
    Sinha, Sweta
    Marks, Jeffrey R.
    Conejo-Garcia, Jose R.
    Alberg, Anthony J.
    Bandera, Elisa, V
    Berchuck, Andrew
    Bondy, Melissa L.
    Christensen, Brock C.
    Cote, Michele L.
    Doherty, Jennifer Anne
    Moorman, Patricia G.
    Peters, Edward S.
    Segura, Carlos Moran
    Nguyen, Jonathan, V
    Schwartz, Ann G.
    Terry, Paul D.
    Wilson, Christopher M.
    Fridley, Brooke L.
    Schildkraut, Joellen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 1006 - 1016
  • [34] Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: A report of two cases
    Parker, RL
    Clement, PB
    Chercover, DJ
    Sornarajah, T
    Gilks, CB
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (03) : 265 - 272
  • [35] Characterization of tumor origin for high-grade serous ovarian carcinoma in three transgenic mouse models
    Roberts, M.
    Sodi, V.
    Wu, C.
    Cho, K.
    Connolly, D.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 88 - 88
  • [36] High-grade neuroendocrine carcinoma
    Rossi, Giulio
    Bisagni, Alessandra
    Cavazza, Alberto
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (04) : 332 - 339
  • [37] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [38] Endometrial high-grade neuroendocrine carcinoma with serous endometrial carcinoma - a case-report
    Abu Qasida, K.
    Al-Shamsi, R. Ruqaiya
    VIRCHOWS ARCHIV, 2020, 477 : S289 - S289
  • [39] Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma: Report of a Series of Cases of an Unusual Phenomenon
    Boyd, Clinton
    McCluggage, W. Glenn
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 368 - 375
  • [40] Patterns of tumor evolution in high grade serous ovarian carcinoma
    Verhaak, Roel G. W.
    Chang, Kyle
    Kim, Hoon
    Carter, Scott L.
    Schultz, Nikolaus
    Zhao, Fengmei
    Shen, Hui
    Laird, Peter
    Sinah, Rileen
    Muzny, Donna
    Reid, Jeff
    Nu, Jiangong
    Drummond, Jennifer
    Getz, Gad
    Levine, Douglas A.
    Wheeler, David A.
    CANCER RESEARCH, 2012, 72